Q&A with Schenk AccuRate's Chad Lorensen

Lorensen discusses client demands and industry trends.
May 02, 2010
By PharmTech Editors

Q & A with
Chad Lorensen, pharmaceutical industry business-development manager of Schenck AccuRate



PharmTech:
What is the biggest industry challenge you're now facing?

Lorensen
The development of continuous manufacturing processes. We are monitoring, helping where we can, and working with companies in the pharmaceutical industry who are studying continuous manufacturing processes for solid dosage products. Our core products have the strengths that provide value for this type of manufacturing process.

PharmTech:
How do you stay abreast of new developments in the industry?

Lorensen
Schenck stays abreast of the latest industry developments through regular communication with our customers, developing strong working relationships with other pharmaceutical-industry equipment manufacturers, and by participating in research consortiums at various universities. Further information is gathered by reviewing various pharmaceutical periodicals and attending trade show exhibitions. In addition, Schenck is a global company, and each of its offices can share ideas with other Schenck locations throughout the world.

PharmTech:
Do you see a new industry trend emerging?

Lorensen
We are looking forward to the pharmaceutical industry's acceptance of continuous mixing, granulation, and hot-melt extrusion.

PharmTech:
What is the most common demand your clients are currently making of you?

Lorensen
The most common request is to provide equipment to customers' sites for trials and experiments made in conjunction with other types of continuous processing equipment.